Hagerty, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Hagerty, Inc. on August 7, 2025, with the earliest event reported on the same date. The filing details the entry into a material definitive agreement regarding a secondary offering of Class A common stock.
Key Financial Metrics and Transaction Details
The filing describes a secondary offering where selling stockholders (The Hagerty Group, LLC, Hagerty Holding Corp., and Aldel LLC) agreed to sell shares. The Company itself is not the primary seller of these shares, though it facilitated the offering.
- Shares Sold: 9,700,000 shares of Class A common stock.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 1,455,000 shares.
- Offering Price: $9.34 per share.
- Underwriters: Keefe, Bruyette & Woods, Inc. and J.P. Morgan Securities LLC.
- Closing Date: August 11, 2025.
Note: This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company's operations. Proceeds from this transaction are expected to go to the Selling Stockholders, not the Company.
Material Changes
The primary material change is the dilution of existing shareholders due to the issuance of new shares into the public market and the change in ownership structure as Selling Stockholders liquidate a portion of their holdings. The filing does not report changes in the Company's operational financials compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risks beyond the standard representations and warranties in the Underwriting Agreement. The transaction was executed pursuant to a previously effective registration statement (No. 333-261810).
Key Facts for Investor Verification
- Verify the final number of shares sold if the 30-day over-allotment option is exercised.
- Confirm the total proceeds received by the Selling Stockholders versus the Company.
- Review the impact of the 9.7 million shares (plus potential over-allotment) on the Company's total share count and earnings per share.
- Check subsequent filings for the final closing statement and any changes in the Selling Stockholders' ownership percentages.